Of 3,500 lakh Covaxin shots, only 8,400 used in Karnataka | Bengaluru News – Times of India
The Made in India vaccine dispatched during the first phase of vaccination in January has been given to only six institutions in the state. The drug expires in May. As per data of the state health and family welfare department, the used Covid-19 vaccine count includes the first and second doses given to recipients.
Covaxin is being administered at Vijayanagar Institute of Medical Sciences, Ballari; Shivammoga Institute of Medical Sciences, Shivamogga; Chamarajanagar Institute of Medical Sciences, Chamarajanagar; Hassan Institute of Medical Sciences, Hassan; Chikkamagaluru district hospital and Davanagere district hospital.
The Phase 3 trial of the drug developed by Bharat Biotech along with ICMR is under way and data is yet to be published. After Prime Minister Narendra Modi took Covaxin on Monday morning at the All India Institute of Medical Sciences, Delhi, several senior citizens here asked why Covaxin can’t be given to them in Bengaluru’s hospitals.
“There’s no choice of vaccine as of now, even when senior citizens pay for it. We need to answer these questions patiently and explain to them the benefits of Covishield,” said a doctor heading a private hospital in Bengaluru.
While the state has seen 21 serious adverse events following vaccination so far, all were post Covishield vaccination. No AEFIs have been reported in the state post-Covaxin administration. “The public ask valid questions. But for us, the mandate is to administer the vaccine supplied by the government. Earlier, there was hesitation with regard to Covaxin as it needed a form to be signed expressing willingness to be a part of thePhase 3 clinical trial,” sources said.
Covaxin from Mid-March Dr Arundhathi Chandrashekar, mission director, National Health Mission, Karnataka said Covaxin will be distributed to some districts by mid-March. “The Centre has not put any restrictions on which vaccine should be used where. We’re allocating them based on supplies. We’ll supply Covaxin to some districts by mid-March. But no institution will be given both vaccines as we want to avoid any possible confusion,” she said.